Selitrectinib
Selitrectinib (LOXO-195) is a highly potent and selective next-generation TRK inhibitor, targeting TrkA and TrkC with IC50 values of 0.6 and <2.5 nM, respectively. It is a valuable research tool for studying TRK-driven cancers, demonstrating activity in both cellular assays and in vivo models of acquired resistance to first-generation TRK inhibitors.
Product Specifications
CAS Number
2097002-61-2
Product Name Alternative
Inhibitor, inhibit, LOXO195, LOXO-195, LOXO 195, Selitrectinib, Trk Receptor, Trkreceptor, Trk receptor, Trk, Tropomyosin related kinase receptor
Field of Research
Signal Transduction
Purity
≥95% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.26 mM) ; DMSO:65 mg/mL (170.86 mM)
Smiles
[H][C@]12CCCN1c1ccn3ncc (C (=O) N[C@H] (C) CCc4ncc (F) cc24) c3n1
Molecular Formula
C20H21FN6O
Molecular Weight
380.42
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Explore Other Products
Browse additional items from our catalog
Recombinant Mycobacterium ulcerans Urease accessory protein UreG (ureG)
Recombinant Mycobacterium ulcerans Urease accessory protein UreG (ureG)
Recombinant Mycobacterium ulcerans Urease accessory protein UreG (ureG)
Recombinant Mycobacterium ulcerans Urease accessory protein UreG (ureG)
Recombinant Mycobacterium ulcerans Urease accessory protein UreG (ureG)